EUVIMEDEUVIMED entdecken
Crossref

Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk Groups

Ghassan Zammar, Bradley Augustson, Elizabeth Moore, Cameron Wellard, Elham Ashrafi, Hasib Sidiqi, Kenneth J C Lim, Dejan Radeski, Alannah Jackson, Krystal Bergin, Simon Harrison, P Joy Ho und 9 weitere

Clinical Lymphoma Myeloma and Leukemia · 2025

DOI: 10.1016/j.clml.2025.12.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2025. Verfasst von Ghassan Zammar und 20 weiteren Autor:innen. Beteiligte Einrichtung: Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Electronic address: Ghassan.Zammar@health.wa.gov.au. Hauptthemen laut MEDLINE: Multiple Myeloma, Cytogenetic Analysis. Die Arbeit nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Multiple MyelomaCytogenetic AnalysisHumansMaleFemaleAgedMiddle AgedChromosome AberrationsAged, 80 and overPrognosisIn Situ Hybridization, FluorescenceAdult

Stichwörter der Autor:innen

Clinical outcomesCytogeneticsResponseSurvivalTreatment

Autor:innen und Institutionen

  • Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia. Electronic address: Ghassan.Zammar@health.wa.gov.au.
  • Haematology, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia.
  • School of Public Health and Preventive Medicine, Monash University, Melbourne, Victoria, Australia.
  • Fiona Stanley Hospital, Perth, Western Australia, Australia.
  • St Vincent's Hospital, Melbourne, Victoria, Australia.
  • The Alfred Hospital, Melbourne, Victoria, Australia.

Zitieren

APA

Zammar, G., Augustson, B., Moore, E., Wellard, C., Ashrafi, E., Sidiqi, H., Lim, K. J. C., Radeski, D., Jackson, A., Bergin, K., Harrison, S., Ho, P. J., King, T., Quach, H., Mollee, P., Rajagopal, R., Rosengarten, B., Wood, E., McQuilten, Z., …, & Australian and New Zealand Myeloma and Related Diseases Registry investigators (2025). Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk Groups. Clinical Lymphoma Myeloma and Leukemia. https://doi.org/10.1016/j.clml.2025.12.005

Vancouver

Zammar G, Augustson B, Moore E, Wellard C, Ashrafi E, Sidiqi H, et al. Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk Groups. Clinical Lymphoma Myeloma and Leukemia. 2025. doi:10.1016/j.clml.2025.12.005

BibTeX
@article{Zammar2025,
  author = {Zammar, Ghassan and Augustson, Bradley and Moore, Elizabeth and Wellard, Cameron and Ashrafi, Elham and Sidiqi, Hasib and Lim, Kenneth J C and Radeski, Dejan and Jackson, Alannah and Bergin, Krystal and Harrison, Simon and Ho, P Joy and King, Tracy and Quach, Hang and Mollee, Peter and Rajagopal, Rajeev and Rosengarten, Brian and Wood, Erica and McQuilten, Zoe and Spencer, Andrew and Australian and New Zealand Myeloma and Related Diseases Registry investigators, Australian and New Zealand Myeloma and Related Diseases Registry investigators},
  title = {Cytogenetic Testing in Newly Diagnosed Multiple Myeloma: Real World Evidence on Clinical Features and Adverse Outcomes for High Risk Groups},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2025},
  doi = {10.1016/j.clml.2025.12.005}
}
Kostenlos starten →